Literature DB >> 11918576

Oro-facial pain in the community: prevalence and associated impact.

Tatiana V Macfarlane1, Anthony S Blinkhorn, Robin M Davies, John Kincey, Helen V Worthington.   

Abstract

STUDY
OBJECTIVE: To determine the prevalence of oro-facial pain (OFP) in the population and within-population subgroups and to describe the associated disability.
DESIGN: Cross-sectional population study.
SETTING: General medical practice in South East Cheshire, United Kingdom. PARTICIPANTS: A random sample of 4000 adults aged 18-65 years of whom 2504 responded (adjusted participation rate 74%). MAIN
RESULTS: The overall prevalence of OFP was 26% (95% Confidence Interval (CI) 24%, 28%). The prevalence of symptoms was higher in women (30%) than in men (21%) and in both sexes the highest (30%) prevalence was found in the 18-25 year age group and the lowest (22%) in the 56-65 age group. Of all the participants, 12% had pain in or around the eyes, 10% reported pain in and around the temples, 6% pain in front of the ears and 6% pain in the jaw joints. Only 46% of the participants with OFP had sought professional advice from a dentist or general medical practitioner and 17% had to take time off work or were unable to carry out normal activities because of pain.
CONCLUSIONS: OFP is a common symptom experienced by a quarter of the adult population, of whom only 46% seek treatment. The prevalence is higher in women and younger age groups.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11918576     DOI: 10.1034/j.1600-0528.2002.300108.x

Source DB:  PubMed          Journal:  Community Dent Oral Epidemiol        ISSN: 0301-5661            Impact factor:   3.383


  53 in total

1.  Tweeting about pain: comparing self-reported toothache experiences with those of backaches, earaches and headaches.

Authors:  Kristina Ahlwardt; Natalie Heaivilin; Jennifer Gibbs; Jens Page; Barbara Gerbert; Janice Y Tsoh
Journal:  J Am Dent Assoc       Date:  2014-07       Impact factor: 3.634

Review 2.  Chronic orofacial pain.

Authors:  Sowmya Ananthan; Rafael Benoliel
Journal:  J Neural Transm (Vienna)       Date:  2020-03-04       Impact factor: 3.575

Review 3.  Orofacial pain and headache: a review and look at the commonalities.

Authors:  Steven D Bender
Journal:  Curr Pain Headache Rep       Date:  2014-03

4.  Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study.

Authors:  Inna E Tchivileva; Pei Feng Lim; Shad B Smith; Gary D Slade; Luda Diatchenko; Samuel A McLean; William Maixner
Journal:  Pharmacogenet Genomics       Date:  2010-04       Impact factor: 2.089

5.  Chronic Pain in a Biracial Cohort of Young Women.

Authors:  Octavia Plesh; Stuart A Gansky; Donald A Curtis
Journal:  Open Pain J       Date:  2012

Review 6.  How may stressful experiences contribute to the development of temporomandibular disorders?

Authors:  Gustavo Hauber Gameiro; Annicele da Silva Andrade; Darcy Flávio Nouer; Maria Cecília Ferraz de Arruda Veiga
Journal:  Clin Oral Investig       Date:  2006-08-22       Impact factor: 3.573

7.  Risk factors for onset of chronic oro-facial pain--results of the North Cheshire oro-facial pain prospective population study.

Authors:  Vishal R Aggarwal; Gary J Macfarlane; Tracey M Farragher; John McBeth
Journal:  Pain       Date:  2010-03-20       Impact factor: 6.961

8.  Suspected trigeminal nerve neuropathy causing persistent idiopathic facial pain: a report of four cases.

Authors:  Nicholas Moser; Brad Muir
Journal:  J Can Chiropr Assoc       Date:  2019-08

9.  Prevalence of Various Orofacial Pain Symptoms and Their Overall Impact on Quality of Life in a Tertiary Care Hospital in India.

Authors:  Sukhvinder Singh Oberoi; S S Hiremath; R Yashoda; Charumohan Marya; Amit Rekhi
Journal:  J Maxillofac Oral Surg       Date:  2013-09-14

10.  Prevalence of temporomandibular dysfunction in a group of scuba divers.

Authors:  R D Aldridge; M R Fenlon
Journal:  Br J Sports Med       Date:  2004-02       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.